Use/misuse of over-the-counter medications and associated adverse drug events among HIV-infected patients

Research in Social and Administrative Pharmacy

Volumn 4, Issue 3, 2008, Pages 292-301

  Ajuoga, Elizabeth ^a   Sansgiry, Sujit S ^a   Ngo, Caroline ^b   Yeh, Rosa F ^a  

^a UNIVERSITY OF HOUSTON   (United States)

^b Walgreens Pharmacy   (United States)

Author keywords

Adverse drug events; HIV; Medication use; Misuse; Over the counter medications

Indexed keywords

ANALGESIC AGENT; NON PRESCRIPTION DRUG;

ADDICTION; ADULT; ARTICLE; CHI SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MIDDLE AGED; QUESTIONNAIRE; SELF MEDICATION; UNITED STATES;

ADULT; ANALGESICS, NON-NARCOTIC; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; NONPRESCRIPTION DRUGS; QUESTIONNAIRES; SELF MEDICATION; SUBSTANCE-RELATED DISORDERS; TEXAS;

EID: 51349088957     PISSN: 15517411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sapharm.2007.08.001     Document Type: Article

References (34)

1. National Consumers League. Over-the-counter pain medication study. Available at: (2003). http://www.nclnet.org/otcpain/harrisesummary.htm Accessed 02.20.07
2. Greenblatt R.M., Hollander H., McMaster J.R., and Henke C.J. Polypharmacy among patients attending an AIDS clinic: utilization of prescribed, unorthodox, and investigational treatments. J Acquir Immune Defic Syndr 4 2 (1991) 136-143
3. Smith S.R., Boyd E.L., and Kirking D.M. Nonprescription and alternative medication use by individuals with HIV disease. Ann Pharmacother 33 3 (1999) 294-300
4. Chow R., Chin T., Fong I.W., and Bendayan R. Medication use patterns in HIV-positive patients. Can J Hosp Pharm 46 4 (1993) 171-175
5. Nykamp D., Barnett C.W., Lago M., Parham D.L., and Fernandez E.S. Cost of medication therapy in ambulatory HIV-infected patients. Ann Pharmacother 31 3 (1997) 303-307
6. Furler M.D., Einarson T.R., Walmsley S., Millson M., and Bendayan R. Polypharmacy in HIV: impact of data source and gender on reported drug utilization. AIDS Patient Care STDS 18 10 (2004) 568-586
7. Abbott F.V., and Fraser M.I. Use and abuse of over-the-counter analgesic agents. J Psychiatry Neurosci 23 1 (1998) 13-34
8. Clark D., Layton D., and Shakir S.A. Monitoring the safety of over the counter drugs. We need a better way than spontaneous reports. BMJ 323 7315 (2001) 706-707
9. Tran T., Lowry A.M., and EL-Serag H.B. Meta-analysis: the efficacy of over-the-counter gastro-oesophageal reflux disease therapies. Aliment Pharmacol Ther 25 2 (2007) 143-153
10. Biskupiak J.E., Brixner D.I., Howard K., and Oderda G.M. Gastrointestinal complications of over-the-counter nonsteroidal antiinflammatory drugs. J Pain Palliat Care Pharmacother 20 3 (2006) 7-14
11. Dajani E.Z. Gastrointestinal toxicity of over-the-counter analgesics. Am J Gastroenterol 93 7 (1998) 1020-1022
12. Lewis J.D., Kimmel S.E., Localio A.R., et al. Risk of serious upper gastrointestinal toxicity with over-the-counter nonaspirin nonsteroidal anti-inflammatory drugs. Gastroenterology 129 6 (2005) 1865-1874
13. Farquhar W.B., Morgan A.L., Zambraski E.J., and Kenney W.L. Effects of acetaminophen and ibuprofen on renal function in the stressed kidney. J Appl Physiol 86 2 (1999) 598-604
14. Fored C.M., Ejerblad E., Lindblad P., et al. Acetaminophen, aspirin, and chronic renal failure. N Engl J Med 345 25 (2001) 1801-1808
15. Perneger T.V., Whelton P.K., and Klag M.J. Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs. N Engl J Med 331 25 (1994) 1675-1679
16. Bolesta S., and Haber S.L. Hepatotoxicity associated with chronic acetaminophen administration in patients without risk factors. Ann Pharmacother 36 2 (2002) 331-333
17. Watkins P.B., Kaplowitz N., Slattery J.T., et al. Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial. JAMA 296 1 (2006) 87-93
18. Nebeker J.R., Barach P., and Samore M. Clarifying adverse drug events: a clinician's guide to terminology, documentation, and reporting. Ann Intern Med 140 (2004) 795-801
19. Von Bargen J., Moorman A., and Holmberg S. How many pills do patients with HIV infection take?. JAMA 280 1 (1998) 29
20. Gonzalez-Martin G., Yanez C.G., Gonzalez-Contreras L., and Labarca J. Adverse drug reactions (ADRs) in patients with HIV infection. A prospective study. Int J Clin Pharmacol Ther 37 1 (1999) 34-40
21. Fulco P.P., Vora U.B., and Bearman G.M.L. Acid suppressive therapy and the effects on protease inhibitors. Ann Pharmacother 40 (2006) 1974-1983
22. Lunzen J.V., Liess H., Arasteh K., Walli R., Daut B., and Schurmann D. Concomitant use of gastric acid-reducing agents is frequent among HIV-infected patients receiving protease inhibitor-based highly active antiretroviral therapy. HIV Med 8 (2007) 220-225
23. Covington T.R. Nonprescription Drug Therapy: Guiding Patients Self-Care (1999), Facts and Comparison, St. Louis, MO
24. Pray S.W. Non-prescription Product Therapeutics (1999), Lippincott Williams and Wilkins, Baltimore, MD
25. Chan A.T., Manson J.E., Albert C.M., et al. Nonsteroidal antiinflammatory drugs, acetaminophen, and the risk of cardiovascular events. Circulation 113 12 (2006) 1578-1587
26. Sorensen H.T., Mellemkjaer L., Blot W.J., et al. Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin. Am J Gastroenterol 95 9 (2000) 2218-2224
27. Curhan G.C., Knight E.L., Rosner B., Hankinson S.E., and Stampfer M.J. Lifetime nonnarcotic analgesic use and decline in renal function in women. Arch Intern Med 164 14 (2004) 1519-1524
28. Max B., and Sherer R. Management of the adverse effects of antiretroviral therapy and medication adherance. Clin Infect Dis 30 suppl (2000) S96-S116
29. Caranasos G.J., Stewart R., and Cluff L.E. Drug-induced illness leading to hospitalization. JAMA 228 6 (1974) 713-717
30. Ives T.J., Bentz E.J., and Gwyther R.E. Drug-related admissions to a family medicine inpatient service. Arch Intern Med 147 (1987) 1117-1120
31. Food and Drug Administration, Department of Health and Human Services. Over-the-counter human drugs: labeling requirements, final rule. Fed Regist 13254-13303. Available at: http://www.fda.gov/cder/otc/label/label-frreg.htm. Accessed 05.20.07.
32. Covington T.R. Nonprescription medications and self-care. Nonprescription drug therapy: issues and opportunities. [Article 137]. Am J Pharm Educ 70 6 (2006)
33. Bond C., and Hannaford P. Issues related to monitoring the safety of over-the-counter (OTC) medicines. Drug Saf 26 15 (2003) 1065-1074
34. Consumer Healthcare Products Association (CHPA). OTC retail sales-1964-2005. Available at:. http://www.chpa-info.org/ChpaPortal/PressRoom/Statistics/OTCRetailSales.htm Accessed 03.02.07